Riskpilot← Back to searchSign inGet full accessNoor Vård AB
ABActiveOrg 5569257347Hosjöstrand 166General medical practice activities · NACE 8621Est. 20131 employees
Revenue 2025
SEK 2,5M
+1% vs 2024
EBITDA margin
43.2%
+24% vs 2024
Equity ratio
66.3%
Financial strength
Net profit 2025
SEK 1,1M
+64% vs 2024
| Revenue | SEK 2,5M | +1% |
| EBITDA | SEK 1,1M | +24% |
| Net profit | SEK 1,1M | +64% |
| Total assets | SEK 9M | +8% |
| Equity | SEK 5,9M | +18% |
| Employees | 1 | — |
Legal name
Noor Vård AB
Org number
5569257347
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 mars 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva primärvårdsverksamhet samt därmed förenlig verksamhet.
Address
Hosjöstrand 166
Phone
+46735906800
Email
mohammad.al-chalabi@ltdalarna.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 402 | 1 083 | 1 123 | 2 430 | 2 461 |
| Staff expenses | — | −61 | −127 | −1 458 | −1 171 |
| EBITDA | −648 | 1 037 | 932 | 858 | 1 064 |
| Depreciation & amort. | −80 | −80 | −13 | — | — |
| EBIT | −728 | 958 | 919 | 858 | 1 064 |
| Net financials | — | −0 | 22 | 32 | 787 |
| Profit before tax | −729 | 883 | 931 | 850 | 1 381 |
| Tax | −57 | −191 | −216 | −187 | −291 |
| Net profit | −786 | 692 | 715 | 663 | 1 090 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6 004 | 6 801 | 7 156 | 8 334 | 8 962 |
| Equity | 3 813 | 4 305 | 4 585 | 5 048 | 5 938 |
| Long-term debt | 15 | 15 | 15 | 13 | 20 |
| Short-term debt | 181 | 412 | 476 | 901 | 414 |
| Total debt | 196 | 427 | 491 | 914 | 434 |
EBITDA margin
43.2%
This company
15.8%
Market median
+173% vs market
20212025
Equity ratio
66.3%
This company
38.2%
Market median
+74% vs market
20212025
Return on equity
18.4%
This company
18.4%
Market median
+0% vs market
20212025
Net profit margin
44.3%
This company
8.1%
Market median
+447% vs market
20212025
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20212025
Debt / equity
0.51×
This company
0.62×
Market median
+18% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MH Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Noor Vård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mohammad Hussam A A-M Al-Chalabi | Chief Executive Officer | 0 companies |
| Aseel Modher Raghib | Deputy Board Member | 0 companies |